Approximately 86,000 vertebral fragility fractures occur annually in the UK, with most remaining undiagnosed, according to a press release from Nano-X Imaging Ltd. (NASDAQ: NNOX). Nanox.AI, the company’s medical imaging analytics subsidiary, is targeting this diagnostic gap with two recent announcements that advance its strategy on separate fronts.
First, Nanox.AI has signed an exclusive three-year UK reseller agreement with Vertec Scientific for its HealthOST bone solution. The deal includes minimum annual license commitments, providing a predictable revenue stream and a commercial pathway for the product in a key market. HealthOST is designed to analyze CT scans for bone health indicators, potentially identifying osteoporosis and fracture risk that might otherwise go unnoticed.
Second, a separate optimization project with Intel demonstrates a path for Nanox.AI’s imaging AI framework to run inference locally on hospital hardware rather than relying entirely on the cloud. This could reduce latency, address data privacy concerns, and lower bandwidth requirements, making AI adoption more feasible for hospitals with limited connectivity or strict data governance policies.
The two initiatives reflect a broader opportunity: CT scans ordered for one clinical question often capture additional anatomical information beyond the original indication. In certain cases, routine CT imaging can include information related to the spine, coronary arteries, liver, and other areas, creating an opportunity to support clinical evaluation of findings that may otherwise go unnoticed. Nanox.AI aims to unlock this latent data to improve patient care.
For investors, the UK reseller agreement offers near-term commercial validation, while the Intel collaboration signals a long-term technology roadmap. By enabling on-premise AI processing, Nanox.AI could differentiate itself in a competitive market where cloud costs and data security are top concerns. The company’s dual approach—expanding sales channels and enhancing technical deployment—positions it to capture value from existing imaging workflows.
As https://ibn.fm/NNOX notes, the latest news and updates relating to NNOX are available in the company’s newsroom. The announcements were distributed via InvestorWire, a specialized communications platform that is part of the Dynamic Brand Portfolio at IBN. InvestorWire provides editorial syndication to 5,000+ outlets and social media distribution, among other services. Full terms of use and disclaimers are available at https://www.InvestorWire.com/Disclaimer.
